41
Ga-68-PSMA-11 in High-risk Prostate Cancer
Condition(s):High-risk Prostate Cancer; Prostate Cancer; Prostate Cancer Metastatic; Lymphnode MetastasisLast Updated:July 27, 2020Completed
Metastatic Prostate Carcinoma in the Soft Tissue: 133 Clinical Trials, Page 5 of 14
Hide Studies Not Open or Pending
42
Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
Condition(s):Metastatic Prostate CancerLast Updated:April 3, 2020Completed
43
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Condition(s):Prostatic NeoplasmsLast Updated:March 26, 2021Active, not recruiting
44
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:February 17, 2021Active, not recruiting
45
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition(s):Metastatic Hormone Sensitive Prostate CancerLast Updated:March 30, 2021Active, not recruiting
46
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent
Condition(s):Metastatic Castration-resistant Prostate Cancer; Androgen Resistant Prostatic CancerLast Updated:April 14, 2021Not yet recruiting
47
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
Condition(s):Metastatic Castrate Resistant Prostate CancerLast Updated:November 22, 2019Terminated
48
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Condition(s):Metastatic Castration-Resistant Prostate CancerLast Updated:November 15, 2018Completed
49
ProBio: A Biomarker Driven Study in Patients With Metastatic Castrate Resistant Prostate Cancer
Condition(s):Metastatic Castration-Resistant Prostatic CancerLast Updated:September 16, 2020Recruiting
50
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Condition(s):Adenocarcinoma of the Prostate; Bone Metastases; Soft Tissue Metastases; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate CancerLast Updated:December 3, 2018Completed